BPA Call 36C25523A0024-36C25523N0286
- Not listed
- This federal contract award is for a Blanket Purchase Agreement (BPA) awarded by the Veterans Integrated Service Network 15 (VISN 15) of the U.S. Department of Veterans Affairs (VA) to Accelerate Diagnostics, Inc. The BPA, valued at $57,585.00, is for the provision of a Rapid ID/AST system to the St. Louis VA Medical Center. The system enables rapid identification of pathogens and determination of antibiotic susceptibility, supporting prompt diagnosis and targeted treatment of bloodstream...
- The Department of Veterans Affairs Veterans Health Administration awarded a Blanket Purchase Agreement (BPA) Call contract to Accelerate Diagnostics, Inc., a for-profit manufacturer of in vitro diagnostic products and services. The $57,585.00 contract is for the delivery of a RAPID ID/AST SYSTEM to the St. Louis VA Medical Center. The contract does not have a set-aside designation and will be performed in St. Louis, MO. Accelerate Diagnostics provides phenotyping reagents, test kits, controls,...
- The Department of Veterans Affairs (VA) awarded a Blanket Purchase Agreement (BPA) call to Accelerate Diagnostics, Inc., a for-profit manufacturer of in vitro diagnostic solutions. The $110,100 contract is for the provision of instrumentation, reagents, and test kits to enable rapid identification and antimicrobial susceptibility testing of positive blood cultures at VA medical facilities. This supports prompt diagnosis and treatment of bloodstream infections among veterans. Accelerate...
- The Department of Veterans Affairs Veterans Health Administration awarded a Blanket Purchase Agreement (BPA) to Accelerate Diagnostics, Inc., a for-profit manufacturer of in vitro diagnostic products and services for clinical microbiology laboratories. The BPA, valued at $163,575.00, is for the supply of Accelerate Phenotype systems, modules, blood culture (BC) kits, BC antimicrobial susceptibility testing (AST) quality control (QC) tests, and BC identification QC tests for the St. Louis VA...
- This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Accelerate Diagnostics, Inc., a for-profit manufacturer of in vitro diagnostic products and services for clinical microbiology laboratories. The contract, a Blanket Purchase Agreement (BPA) call with a Firm Fixed Price pricing type, was issued by the VA's Veterans Integrated Service Network (VISN) 15 and has a potential value of $640,935.00. It provides for the supply of instrumentation,...
- This is a contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Accelerate Diagnostics, Inc., a for-profit manufacturer of in vitro diagnostic products and services for clinical microbiology laboratories. The contract is a Blanket Purchase Agreement (BPA) call for Option Year 1, with a firm fixed price of $147,899.47 and a completion date of August 31, 2022. It is a set-aside for small businesses and includes the provision of Accelerate Pheno System,...
- This is a Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Accelerate Diagnostics, Inc., a small business manufacturer of in vitro diagnostic products and services for clinical microbiology laboratories. The BPA, valued at $152,025.00, is for the supply of the Accelerate Pheno System, associated modules, blood culture kits, and quality control tests for the VA St. Louis Medical Center. This contract supports the VA's...
- This federal contract award to Accelerate Diagnostics, Inc. is for the supply of the company's Accelerate Pheno in vitro diagnostic system and associated products. The contract, identified as 36F79718D0391|36C24724F0083, is a Delivery Order placed against the company's General Services Administration (GSA) Federal Supply Schedule (FSS) contract for In Vitro Diagnostics, Reagents, and Test Kits. The contract, awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm-fixed-price purchase order to Accelerate Diagnostics, Inc., a for-profit manufacturer of in vitro diagnostic products and services, to provide a Bloodstream Infection Diagnosis System for the Cleveland Louis Stokes VA Medical Center. The $110,000.00 contract has a completion date of April 27, 2019. Accelerate Diagnostics has previously supplied phenotyping reagents, test kits, controls, and systems to support...
- This federal contract award, valued at $393,602.00, was made by the Veterans Integrated Service Network 7 (VISN 7), a civilian agency under the U.S. Department of Veterans Affairs (VA), to Accelerate Diagnostics, Inc., a for-profit manufacturer based in Tucson, Arizona. The contract is a firm-fixed-price purchase order with a completion date of February 28, 2027. The contract is for the procurement of the Accelerate Pheno system, which enables rapid identification of pathogens and...
- 36C25523A0024Blanket Purchase Agreement
- 36C25523A0024-36C25523N0286BPA Call
This federal contract award is for a Blanket Purchase Agreement (BPA) between the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 15 and Accelerate Diagnostics, Inc., a for-profit manufacturer of in vitro diagnostic products and services. The BPA, valued at $57,186, provides the St. Louis VA Medical Center with a Rapid ID/AST (Identification/Antimicrobial Susceptibility Testing) system, including instrumentation and associated consumables. This contract supports the VA's mission to provide timely and effective care for veterans through optimized treatment of infections, as the Rapid ID/AST system enables faster identification of pathogens and determination of appropriate antibiotic treatments. The contract is a Firm Fixed Price BPA Call and does not have a set-aside designation. Accelerate Diagnostics has also been awarded a separate BPA by VA VISN 16, valued at $550,500, to supply instrumentation, reagents, and test kits for rapid ID/AST analysis of positive blood cultures at multiple VA medical facilities. Additionally, the company has received federal grant sub-awards to support its research and development efforts, including projects focused on advancing diagnostic technologies to address the growing threat of antimicrobial resistance.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($200) | 8/27/24 | |
| Not listed | Not listed | $57.4k | 5/17/23 |